International Myeloma Foundation
International Myeloma Foundation
Want to make a donation using Daffy?
Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.
Do you work for International Myeloma Foundation? Learn more here.
By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.
About this organization
Mission
The mission of the International Myeloma Foundation (IMF) is to improve the quality of life of myeloma patients while working toward prevention and a cure. The IMF was founded in 1990 to provide myeloma patients with comprehensive education and support while actively supporting research and advocacy for the cause.
About
Research - The International Myeloma Foundation (IMF) is the leader in globally collaborative myeloma research. IMF supports lab-based research and has awarded over 146 grants to top junior and senior research scientists since 1995. In addition, IMF brings together the world's leading experts in the most successful and unique way through the International Myeloma Working Group, which is publishing in prestigious medical journals, charting the course to a cure, mentoring the next generation of innovative investigators, and improving lives through better care. The Black Swan Research Initiative is a multinational consortium of leading myeloma experts who are harnessing new technologies and the latest myeloma treatments to find a pathway to a cure. The Black Swan Research Strategy capitalizes on the availability of potent novel therapies and the advent of ultra-sensitive tests to measure exactly when and how those therapies are working in patients. The Black Swan Research Initiative is dedicated to developing new curative therapies for myeloma.
Interesting data from their 2020 990 filing
The filing documents outline the non-profit's mission as “Dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure.”.
When outlining the tasks it performs, they were referred to as: “Dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure.”.
- The non-profit's reported state of operation is CA as per legal requirements.
- The filing reveals that the address of the non-profit in 2020 is 12650 RIVERSIDE DRIVE SUITE 206, NORTH HOLLYWOOD, CA, 91607.
- As of 2020, the non-profit has 48 employees reported on their 990 form.
- Is not a private foundation.
- Expenses are greater than $1,000,000.
- Revenue is greater than $1,000,000.
- Revenue less expenses is $694,692.
- The organization has 16 independent voting members.
- The organization was formed in 1990.
- The organization pays $5,954,445 in salary, compensation, and benefits to its employees.
- The organization pays $1,242,145 in fundraising expenses.